Telcon RF Pharmaceutical

(주)텔콘알에프제약 · KOSDAQ · 200230 · Industry: Manufacture of medicaments

Key metrics

Earnings

Revenue, Q3 2026₩27.5bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-4.8% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+180.3% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026-₩3.0bn As of Sep 30, 2026 Source 1 ↗
Operating income QoQ-276.3% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY-34937.3% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months5,329,916 shares As of Jul 6, 2026 Source 1 ↗, Source 2 ↗
Potential new shares, last 12 months10,743,268 shares As of Jul 31, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗
Potential new shares, % of shares113.3% As of Jul 31, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Conversion price adjustments, last 12 months3 As of Jul 31, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗

Supply contracts

Supply contracts, last 12 months₩5.9bn As of Oct 26, 2026 Source 1, Source 2
Supply contracts vs prior-year revenue13.6% As of Oct 26, 2026 Source 1, Source 2
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months4 As of Nov 19, 2026
DART filings, previous 3 months20 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market buys, last 12 months (amount)₩0 As of Nov 19, 2026
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)0 shares As of Nov 19, 2026
Insiders who bought, last 12 months0 As of Nov 19, 2026

Insider transactions (last 12 months)

Open-market buys: 0 shares (₩0). Open-market sells: 0 shares (₩0). Net open-market buying: 0 shares. Insiders who bought: 0.

Trade dateInsider (role)TypeSharesPriceAmount
Jul 15, 2026Ebeokoeoinbeseuteumeonteuholdingseu Co., Ltd. (Controlling shareholder)Other (Paid-in new shares)+2,329,916 shares——
Jul 10, 2026NUON CO., LTD (Controlling shareholder)Other (OTC sell)-660,000 shares——
Jul 10, 2026Ebeokoeoinbeseuteumeonteuholdingseu Co., Ltd. (Controlling shareholder)Other (OTC buy)+660,000 shares——
Jun 6, 2026NUON CO., LTD (Controlling shareholder)Other (Capital reduction)-12,362,844 shares——
Apr 17, 2026NUON CO., LTD (Controlling shareholder)Other (Paid-in new shares)+3,000,000 shares——

Annual financials

YearRevenueOperating income
2025₩43.2bn₩719m
2024₩37.9bn-₩71m
2023₩36.3bn₩965m

Filing timeline